Popular on Rezul
- Cays Realty Launches AI-Powered South Florida Property Search Platform - 429
- Denver Rent Report, October 2026: Median 1-Bedroom About $1,980, 7 in 10 Communities Offer Specials - 337
- Revinate launches hospitality's first data activation platform - 314
- Parade of Homes Winners Announced - 303
- Cravey Real Estate Services, Inc. Facilitates Sale of Former Bay Car Wash Property in Aransas Pass - 291
- Geospatial Innovation Comes to Sacramento: FOSS4G NA 2026 - 257
- Oakcrest Outdoors Completes Entrance Landscape Makeover at Canopy Oaks - 252
- Zhengxin Chicken Steak Opens at South Hills Plaza in West Covina - 236
- Corner Property Management Awarded Management Contract with Clock Towers Condominium Association - 235
- Elmington Residential Acquires 260-Unit Workforce Housing Community in Atlanta, GA - 206
Similar on Rezul
- FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
- Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
- New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
- Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
- Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
- Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Win Gold in Raleigh's Best Awards for Second Consecutive Year
- Mr Hospital Bed Cites Hill Rom Hospital Bed Models Best Value Home Care Hospital Beds 2026
- Hospital Direct Medical Equipment Company Seeing Growth in Used Refurbished Medical Equipment Sales
- Soft & Sweet Unveils New Studio Location and Website for All-Natural Sugaring in Las Vegas
- Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event
The Vascular Care Group Welcomes Vascular Surgeons Dr. Jessica Feliz and Dr. Ryan Gedney
Rezul News/10750092
DARIEN, Conn. - Rezul -- The Vascular Care Group (TVCG) has expanded its team with the addition of vascular surgeons Jessica Dominique Feliz, MD, and Ryan Gedney, MD, who began seeing patients on October 5, 2026. Dr. Feliz is caring for patients at TVCG's Lowell, Massachusetts vascular center, and Dr. Gedney is practicing at TVCG's Darien and Stamford, Connecticut offices. Both physicians bring advanced training in open and endovascular surgery to the platform, expanding access to comprehensive vascular care for patients in the Merrimack Valley and Fairfield County.
Dr. Feliz completed her general surgery residency at Brigham and Women's Hospital and Harvard Medical School, followed by a vascular surgery fellowship at NewYork-Presbyterian Hospital through Columbia University Irving Medical Center and Weill Cornell Medical Center, two of the nation's premier vascular programs. Her clinical expertise spans open and endovascular surgery, with a focus on limb salvage, peripheral artery disease, carotid disease, dialysis access, and complex aortic pathology.
More on Rezul News
"I'm honored to join The Vascular Care Group and to care for patients in Lowell," said Dr. Feliz. "Whether a patient is living with peripheral artery disease, needs dialysis access, or is working to save a limb, my goal is to provide expert, compassionate care that meets every patient where they are."
Dr. Gedney earned his medical degree and completed his integrated vascular surgery residency at the Medical University of South Carolina. Beyond the operating room, he is the co-inventor of multiple patented and patent-pending technologies, including a novel endovascular aortic arch stent graft, and a co-founder of the medical device startup Anchor Medical, Inc.
"Joining The Vascular Care Group gives me the opportunity to bring the latest in endovascular and open vascular surgery to patients in Darien, Stamford, and the surrounding communities," said Dr. Gedney. "I'm passionate about finding better ways to treat vascular disease, and I look forward to partnering with patients and referring physicians across Fairfield County."
More on Rezul News
The addition of Dr. Feliz and Dr. Gedney strengthens TVCG's ability to deliver specialized vascular care and increases appointment availability for patients in Massachusetts and Connecticut.
About The Vascular Care Group
The Vascular Care Group is one of the largest independent vascular surgery practices in the U.S., specializing in the diagnosis, treatment, and management of vascular conditions. Led by a team of highly skilled vascular surgeons practicing in Massachusetts, Maine, and Connecticut, The Vascular Care Group provides expertise across the full spectrum of vascular disease. Its commitment to advancing vascular medicine through research and education underscores its dedication to improving vascular care and patient outcomes. For more information, visit thevascularcaregroup.com (https://www.thevascularcaregroup.com/).
Dr. Feliz completed her general surgery residency at Brigham and Women's Hospital and Harvard Medical School, followed by a vascular surgery fellowship at NewYork-Presbyterian Hospital through Columbia University Irving Medical Center and Weill Cornell Medical Center, two of the nation's premier vascular programs. Her clinical expertise spans open and endovascular surgery, with a focus on limb salvage, peripheral artery disease, carotid disease, dialysis access, and complex aortic pathology.
More on Rezul News
- Nine MLS Boards, Nine Different Rules for Disclosing Virtually Staged Photos
- Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
- P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
- Logicraft Launches FuelDeckâ˘, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
- Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
"I'm honored to join The Vascular Care Group and to care for patients in Lowell," said Dr. Feliz. "Whether a patient is living with peripheral artery disease, needs dialysis access, or is working to save a limb, my goal is to provide expert, compassionate care that meets every patient where they are."
Dr. Gedney earned his medical degree and completed his integrated vascular surgery residency at the Medical University of South Carolina. Beyond the operating room, he is the co-inventor of multiple patented and patent-pending technologies, including a novel endovascular aortic arch stent graft, and a co-founder of the medical device startup Anchor Medical, Inc.
"Joining The Vascular Care Group gives me the opportunity to bring the latest in endovascular and open vascular surgery to patients in Darien, Stamford, and the surrounding communities," said Dr. Gedney. "I'm passionate about finding better ways to treat vascular disease, and I look forward to partnering with patients and referring physicians across Fairfield County."
More on Rezul News
- Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England
- Virtual Results Puts AI to Work for Home Buyers and Sellers, Not Just Agents
- K2 Global / Ozi Amanat Named Among Top 100 AI Venture Capitalists in 2026
- 303 Crown Maids Brings Transparent, Reliable Cleaning Services to Superior
- Dr. Latorial Faison Appointed Poet Laureate of Virginia
The addition of Dr. Feliz and Dr. Gedney strengthens TVCG's ability to deliver specialized vascular care and increases appointment availability for patients in Massachusetts and Connecticut.
About The Vascular Care Group
The Vascular Care Group is one of the largest independent vascular surgery practices in the U.S., specializing in the diagnosis, treatment, and management of vascular conditions. Led by a team of highly skilled vascular surgeons practicing in Massachusetts, Maine, and Connecticut, The Vascular Care Group provides expertise across the full spectrum of vascular disease. Its commitment to advancing vascular medicine through research and education underscores its dedication to improving vascular care and patient outcomes. For more information, visit thevascularcaregroup.com (https://www.thevascularcaregroup.com/).
Source: The Vascular Care Group
0 Comments
Latest on Rezul News
- Niceville, Shalimar and Fort Walton Beach Sellers: The Scary Part Is the Competition, Not Halloween
- South Austin Real Estate Splits in Two: Circle C Has 4.3 Months of Supply While 78704 Has 8
- ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
- International Misophonia Foundation Launches Sensory Accessible Technology Initiative to Address Overlooked Digital Accessibility Barriers
- The Robert Travers Team of Long & Foster Marks 300+ Homes Sold, Expands Seller Representation
- RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
- Polson's ZJ Rentals Grows Across Western Montana, Pairing Local Service With Its Own Owner Portal
- RELTO Publishes a Free MLS Photo Rules Database and Asks Every MLS to Correct It
- Washington DC Commercial Real Estate Brokerage Calls for Greater Accountability in Property Leasing
- Refervia Launches in Atlanta to Keep Real Estate, Insurance and Mortgage Referrals on Track
- Denver Agent Publishes 2026 House Hacking Guide
- Heritage at Manalapan Announces New 3.875% First-Year Mortgage Rate Buydown (7.11 APR)
- Irina Ahdoot Expands Scottsdale Guide to Help Luxury Buyers Compare Communities
- Irina Ahdoot Shares an Honest Look at What Buyers Should Know Before Moving to Arizona
- Irina Ahdoot Expands Paradise Valley Buyer Guide With Luxury Market Insights
- AthleteMerch.com Surpasses 100,000 Custom Items Delivered to Fans Nationwide
- Steve Weclew is Appointed by STS Capital Partners as Managing Director
- New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight
- Stone & Leaf Landscaping Elevates Outdoor Living with Integrated Lighting Design
- Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma